2020-12-24 08:35:17 GMT2020-12-24 16:35:17(Beijing Time) Xinhua English
SAO PAULO, Dec. 23 (Xinhua) Brazil s state-run Butantan Institute on Wednesday announced that the CoronaVac vaccine developed by the private Chinese laboratory Sinovac Life Science achieved the levels of efficacy against the coronavirus required by the World Health Organization (WHO) in trials with 13,000 Brazilian volunteers. The data corroborate that it is the safest vaccine on the market and we achieved the superiority in efficacy required by the WHO and Brazil s Health Regulatory Agency (Anvisa), Dimas Covas, director of the institute, said at a press conference.
The level of efficacy required by the WHO is greater than 50 percent, he said.
Brazil receives 2.1 million doses of Chinese vaccine against Covid-19
Brazil receives 2.1 million doses of Chinese vaccine against Covid-19
Brasilia, Dec 24 (Prensa Latina) The government of Sao Paulo received 2.1 million doses of CoronaVac, the anti-Covid-19 vaccine developed by Chinese biopharmaceutical Sinovac Biotech in association with the Brazilian state s Butantan Institute.
Also in the cargo, which arrived at the São Paulo airport of Viracopos in Campinas, enough supplies arrived for the production of three million CoronaVac. It was the fourth batch sent by Sinovac.
According to Butantan, CoronaVac achieves the levels of efficacy against the disease required by the World Health Organization (WHO). Data corroborate that it is the safest vaccine on the market and we achieved the superiority in efficacy demanded by the WHO and the Brazilian Health Surveillance Agency (Anvisa), said the director of Butantan, Dimas Covas.
Brazil s Butantan Institute announces efficacy of China s CoronaVac vaccine on Brazilian volunteers - Xinhua xinhuanet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from xinhuanet.com Daily Mail and Mail on Sunday newspapers.